Benign form of monogenic obesity conferred by the melanocortin 4 receptor
Authors:
- 6 January 2026
- journal article
- review article
- Published by Elsevier in Cell Metabolism
- Vol. 38 (1) , 12-13
Abstract
No abstract availableKeywords
Funding Information
- Land Nordrhein-Westfalen
- Deutsche Forschungsgemeinschaft (HI 865/2-1)
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GS0820)
- Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen
- Stiftung Universitätsmedizin Essen
This publication has 8 references indexed in Scilit:
- When more is not worse: Genetic subtypes of obesity challenge conventional risk paradigmsCell Metabolism, 2025
- Obesity due to MC4R deficiency is associated with reduced cholesterol, triglycerides and cardiovascular disease riskNature Medicine, 2025
- The promise of new anti-obesity therapies arising from knowledge of genetic obesity traitsNature Reviews Endocrinology, 2022
- The 103I Variant of the Melanocortin 4 Receptor Is Associated with Low Serum Triglyceride LevelsThe Journal of Clinical Endocrinology & Metabolism, 2006
- Large quantitative effect of melanocortin-4 receptor gene mutations on body mass indexJournal of Medical Genetics, 2004
- Melanocortin-4 Receptor Gene Variant I103 Is Negatively Associated with ObesityThe American Journal of Human Genetics, 2004
- Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor GeneNew England Journal of Medicine, 2003
- Phenotypes in Three Pedigrees with Autosomal Dominant Obesity Caused by Haploinsufficiency Mutations in the Melanocortin-4 Receptor GeneThe American Journal of Human Genetics, 1999